HEALTH AND SOCIAL CARE MODELLING AND INFORMATICS SEMINARS 2002/03*
________________________________________________________________________________
All seminars are Tuesdays at 17:00 in room 5.05, at 9-18 Euston Centre, London
(off Drummond Street, nearest tube: Warren Street)
________________________________________________________________________________
Date: 15 October 2002
Speaker: Dr Chris Sherlaw-Johnson, Clinical Operational Research Unit, UCL,
London
Title: Cervical cancer screening in the UK: can recent scientific advances
improve it?
Abstract: In the UK, women are requested to attend for regular cervical cancer
screening every 3 to 5 years between the ages of 21 and 64. The current
screening test, the Pap smear, is known to be not entirely accurate, and
several controversies have arisen over misdiagnosis and misreporting of test
results. In recent years a number of scientific advances have led to ideas for
improving cervical screening. These include exploiting the link between
cervical cancer and human papillomavirus (HPV) by incorporating HPV testing.
There are also new methods for preparing and reading smear test samples which
could improve the accuracy of diagnosis. This paper will describe how these
advances in screening have been evaluated using a stochastic modelling
approach.
________________________________________________________________________________
Date: 12 November 2002
Speaker: Prof Peter Millard, HSCMG, University of Westminster and St. George’s
Hospital, London
Title: TBC
Abstract: TBC
________________________________________________________________________________
Date: 10 December 2002
Speaker: Dr Radmila Juric, Information Systems, University of Westminster,
London
Title: Applying component-based modelling in the process of evaluation of
medicinal products
Abstract: Medicinal products’ evaluation and registration are the most
important tasks undertaken by government health departments and agencies in
almost every country in the world. The independent evaluation of medicinal
products is based on strictly defined regulatory activities, in order to ensure
that all standards on testing, manufacturing and controlling medicinal products
are achieved. However, each country has its own system of evaluating medicinal
products which differ amongst themselves not only in vocabulary and definitions
of medicinal products, but also in different organisational structures and
evaluation practices of individual health authority bodies. This represents a
serious drawback for efficient local and worldwide registration of medicinal
products. In this paper we address this problem by describing a component-
based software architecture that would facilitate the automation of medicinal
products’ evaluation and registration, which is seen as a critical task that
can dramatically improve the efficiency and efficacy of regulatory activities
across different countries and legislations. We employ our component model
within a commercially available distributed component platform and place our
generic architecture within standards in healthcare information systems,
Distributed Healthcare Environment (DHE) and their associated middleware
concepts.
-----------
Dr. T.J. Chaussalet
University of Westminster
CSCS, Dept of Mathematics
9-18 Euston Centre
London NW1 3ET, UK
Tel: +44(0)207 911 5000 ext 4310
Fax: +44(0)207 915 5438
Email: [log in to unmask]
-----------
PLEASE READ: This e-mail and its attachments are intended for the above
named only and may be confidential. If they have come to you in error you
must not copy or show them to anyone, nor should you take any action based
on them, other than to notify the error by replying to the sender.
Any views expressed in this message are those of the individual sender,
except where the sender specifically states otherwise.
|